Сравнение на методи
Прегледайте избраните методи един до друг; редовете с разлики са откроени.
| Година коригирана по качество на живота (QALY)× | Анализ на разходите и ефективността (АРЕ)× | |
|---|---|---|
| Област | Икономика на здравеопазването | Икономика на здравеопазването |
| Семейство | Process / pipeline | Process / pipeline |
| Година на възникване≠ | 1985 | 1984 |
| Създател≠ | Alan Williams (Health Economics Research Centre, Oxford University) | Drummond & Stoddart (Health Economics Research Group, McMaster University) |
| Тип | Method | Method |
| Основополагащ източник≠ | Kind, P. (1989). The EuroQol instrument: an index of health-related quality of life. In B. Teeling Smith (Ed.), Measuring health: a practical approach. Chichester: Wiley. link ↗ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. New York: Oxford University Press. link ↗ |
| Други названия≠ | QALY, health utility measure | CEA, ICER, Incremental Cost-Effectiveness Ratio |
| Свързани | 5 | 5 |
| Резюме≠ | A QALY measures health benefit as utility weight (0 = death, 1 = perfect health) multiplied by time lived. Developed by Alan Williams in 1985, QALYs enable comparison of disparate health interventions on a common metric. Used globally by health technology assessment bodies—NICE (UK), HAS (France), CADTH (Canada), WHO—to decide which treatments deserve public funding. | Cost-effectiveness analysis compares the incremental cost per unit of health benefit gained by one intervention relative to a comparator (standard care or best alternative). Developed rigorously in the 1980s by Drummond, Stoddart, and colleagues, CEA is now the standard framework for technology appraisal globally. NICE, HAS, CADTH, and other health technology assessment bodies use CEA to decide which treatments warrant public funding and at what price. |
| ScholarGateНабор от данни ↗ |
|
|